Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Taysha Gene Therapies (TSHA) Asset Utilization Ratio (2022 - 2025)

Historic Asset Utilization Ratio for Taysha Gene Therapies (TSHA) over the last 4 years, with Q3 2025 value amounting to 0.02.

  • Taysha Gene Therapies' Asset Utilization Ratio fell 6272.82% to 0.02 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.02, marking a year-over-year decrease of 6272.82%. This contributed to the annual value of 0.05 for FY2024, which is 5158.74% down from last year.
  • As of Q3 2025, Taysha Gene Therapies' Asset Utilization Ratio stood at 0.02, which was down 6272.82% from 0.03 recorded in Q2 2025.
  • Over the past 5 years, Taysha Gene Therapies' Asset Utilization Ratio peaked at 0.09 during Q1 2024, and registered a low of 0.03 during Q4 2022.
  • Moreover, its 4-year median value for Asset Utilization Ratio was 0.05 (2023), whereas its average is 0.05.
  • Its Asset Utilization Ratio has fluctuated over the past 5 years, first skyrocketed by 52679.32% in 2024, then tumbled by 6272.82% in 2025.
  • Over the past 4 years, Taysha Gene Therapies' Asset Utilization Ratio (Quarter) stood at 0.03 in 2022, then surged by 362.47% to 0.08 in 2023, then plummeted by 41.65% to 0.05 in 2024, then plummeted by 60.32% to 0.02 in 2025.
  • Its Asset Utilization Ratio stands at 0.02 for Q3 2025, versus 0.03 for Q2 2025 and 0.05 for Q1 2025.